Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

ASMALIN SYRUP 1.5 mg/5 ml

Approval Number

SIN07055P

Drug Name

ASMALIN SYRUP 1.5 mg/5 ml

Product Name

ASMALIN SYRUP 1.5 mg/5 ml

Approval Date

June 12, 1992

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Pharmacy Only

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R03CC03

ATC Item Name

terbutaline

Manufacturer Information

Pharmaceutical Manufacturer

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Manufacturers

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

Ingredient Name

TERBUTALINE SULPHATE

Strength

1.5 mg/5 ml

Drug MonographTerbutaline

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy